Northumbria Healthcare NHS Foundation Trust, Wansbeck General Hospital, Ashington, UK.
Northern England Clinical Network, NHS England, Newcastle upon Tyne, UK.
J Prim Care Community Health. 2020 Jan-Dec;11:2150132719894758. doi: 10.1177/2150132719894758.
Many patients are prescribed anticoagulants. Newer non-vitamin K oral anticoagulants, NOACs, were launched in 2008 and are increasingly commonly used. However, they may still be unfamiliar to patients and health care professionals. It is mandated by the National Patient Safety Agency and European Society of Cardiology to provide written safety information for patients receiving anticoagulants. We developed a standard patient alert card with the support of the North of England Strategic Clinical network (NESCN) to clearly provide key safety information for patients and health care professionals. This is the only card in the United Kingdom that is used over such a wide geographical area. We recognized that this would avoid duplication of work devising a similar card across all the sites in primary and secondary care. Given that staff and patients commonly move about the region it would also lead to better ease of recognition. The NESCN card was developed with input from all the key stakeholders, including cardiology, stroke, hematology, acute medicine, primary care, and patient groups. It was launched in 2015 across the Northern region, which includes over 3 million people. It was distributed to general practitioners (GPs), primary and secondary care pharmacists. Electronic and face-to-face education was carried out alongside to pharmacists, GPs, and hospital physicians. We gathered patient and clinical staff feedback regarding the card and found the alert card was widely embedded within practice across the region and patient feedback was good. The evaluation shows a simple and inexpensive intervention delivered with no formal funding can address this patient safety concern. We have engaged with Clinical Commissioning Groups and secondary care trusts in the region to ensure the legacy of the project. In response to requests from other regions and organizations, the card has been widely shared and implemented across many areas of the United Kingdom.
许多患者都被开了抗凝剂。新型非维生素 K 口服抗凝剂(NOAC)于 2008 年推出,使用越来越普遍。然而,它们可能仍然不为患者和医疗保健专业人员所熟悉。根据国家患者安全局和欧洲心脏病学会的规定,为接受抗凝治疗的患者提供书面安全信息是强制性的。在英格兰北部战略临床网络(NESCN)的支持下,我们开发了一种标准的患者警示卡,为患者和医疗保健专业人员提供关键安全信息。这是英国唯一在如此广泛的地理区域内使用的卡片。我们认识到,这将避免在初级和二级保健的所有站点设计类似卡片的重复工作。鉴于员工和患者经常在该地区流动,这也将提高识别的便利性。该 NESCN 卡是在包括心脏病学、中风、血液学、急症医学、初级保健和患者团体在内的所有主要利益相关者的投入下开发的。它于 2015 年在包括 300 多万人的北部地区推出。它分发给全科医生(GP)、初级和二级保健药剂师。同时还对药剂师、全科医生和医院医生进行了电子和面对面的教育。我们收集了患者和临床工作人员对该卡片的反馈意见,发现该警示卡在该地区的实践中得到了广泛应用,患者反馈良好。评估表明,一种简单且廉价的干预措施,无需正式资金即可解决这一患者安全问题。我们已与该地区的临床委托组和二级保健信托基金进行了接触,以确保该项目的传承。应其他地区和组织的要求,该卡片已在英国的许多地区得到广泛分享和实施。